Yep. The possibilities are either (a) ineptitude/overpromising/inability to meet a deadline or (b) the scoping study is so unfavourable that it's better to delay and try to improve it than to release, even at the cost of shredding credibility. Both terrible options.
Yep. The possibilities are either (a)...
Add E25 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.035(13.7%) |
Mkt cap ! $63.08M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 29.0¢ | 26.0¢ | $88.41K | 332.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22638 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 29999 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
0.035 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 26.0¢ | 27.5¢ | 26.0¢ | 102940 | ||
| Last updated 15.18pm 10/05/2024 ? | |||||
| E25 (ASX) Chart |